PURPOSE: High-resolution magnetic resonance imaging (MRI) at 4 Tesla depicts details of the internal structure of the hippocampus not visible at 1.5 Tesla, and so allows for in vivo parcellation of different hippocampal subfields. The aim of this study was to test if distinct subfield atrophy patterns can be detected in temporal lobe epilepsy (TLE) with mesial temporal sclerosis (TLE-MTS) and without (TLE-no) hippocampal sclerosis. METHODS: High-resolution T(2)-weighted hippocampal images were acquired in 34 controls: 15 TLE-MTS and 18 TLE-no. Entorhinal cortex (ERC), subiculum (SUB), CA1, CA2, and CA3, and dentate (CA3&DG) volumes were determined using a manual parcellation scheme. RESULTS: TLE-MTS had significantly smaller ipsilateral CA1, CA2, CA3&DG, and total hippocampal volume than controls or TLE-no. Mean ipsilateral CA1 and CA3&DG z-scores were significantly lower than ipsilateral CA2, ERC, and SUB z-scores. There were no significant differences between the various subfield or hippocampal z-scores on either the ipsi- or the contralateral side in TLE-no. Using a z-score <or=-2.0 to identify severe volume loss, the following atrophy patterns were found in TLE-MTS: CA1 atrophy, CA3&DG atrophy, CA1 and CA3&DG atrophy, and global hippocampal atrophy. Significant subfield atrophy was found in three TLE-no: contralateral SUB atrophy, bilateral CA3&DG atrophy, and ipsilateral ERC and SUB atrophy. DISCUSSION: Using a manual parcellation scheme on 4 Tesla high-resolution MRI, we found the characteristic ipsilateral CA1 and CA3&DG atrophy described in TLE-MTS. Seventeen percent of the TLE-no had subfield atrophy despite normal total hippocampal volume. These findings indicate that high-resolution MRI and subfield volumetry provide superior information compared to standard hippocampal volumetry.
PURPOSE: High-resolution magnetic resonance imaging (MRI) at 4 Tesla depicts details of the internal structure of the hippocampus not visible at 1.5 Tesla, and so allows for in vivo parcellation of different hippocampal subfields. The aim of this study was to test if distinct subfield atrophy patterns can be detected in temporal lobe epilepsy (TLE) with mesial temporal sclerosis (TLE-MTS) and without (TLE-no) hippocampal sclerosis. METHODS: High-resolution T(2)-weighted hippocampal images were acquired in 34 controls: 15 TLE-MTS and 18 TLE-no. Entorhinal cortex (ERC), subiculum (SUB), CA1, CA2, and CA3, and dentate (CA3&DG) volumes were determined using a manual parcellation scheme. RESULTS:TLE-MTS had significantly smaller ipsilateral CA1, CA2, CA3&DG, and total hippocampal volume than controls or TLE-no. Mean ipsilateral CA1 and CA3&DG z-scores were significantly lower than ipsilateral CA2, ERC, and SUB z-scores. There were no significant differences between the various subfield or hippocampal z-scores on either the ipsi- or the contralateral side in TLE-no. Using a z-score <or=-2.0 to identify severe volume loss, the following atrophy patterns were found in TLE-MTS: CA1atrophy, CA3&DG atrophy, CA1 and CA3&DG atrophy, and global hippocampal atrophy. Significant subfield atrophy was found in three TLE-no: contralateral SUB atrophy, bilateral CA3&DG atrophy, and ipsilateral ERC and SUB atrophy. DISCUSSION: Using a manual parcellation scheme on 4 Tesla high-resolution MRI, we found the characteristic ipsilateral CA1 and CA3&DG atrophy described in TLE-MTS. Seventeen percent of the TLE-no had subfield atrophy despite normal total hippocampal volume. These findings indicate that high-resolution MRI and subfield volumetry provide superior information compared to standard hippocampal volumetry.
Authors: E De Vita; D L Thomas; S Roberts; H G Parkes; R Turner; P Kinchesh; K Shmueli; T A Yousry; R J Ordidge Journal: Br J Radiol Date: 2003-09 Impact factor: 3.039
Authors: N Bernasconi; A Bernasconi; Z Caramanos; F Dubeau; J Richardson; F Andermann; D L Arnold Journal: Neurology Date: 2001-05-22 Impact factor: 9.910
Authors: Nihal C de Lanerolle; Jung H Kim; Anne Williamson; Susan S Spencer; Hitten P Zaveri; Tore Eid; Dennis D Spencer; Toye Eid Journal: Epilepsia Date: 2003-05 Impact factor: 5.864
Authors: David L Thomas; Enrico De Vita; Steven Roberts; Robert Turner; Tarek A Yousry; Roger J Ordidge Journal: Magn Reson Med Date: 2004-06 Impact factor: 4.668
Authors: Sandhitsu R Das; Brian B Avants; John Pluta; Hongzhi Wang; Jung W Suh; Michael W Weiner; Susanne G Mueller; Paul A Yushkevich Journal: Neuroimage Date: 2012-01-28 Impact factor: 6.556
Authors: Maged Goubran; David A Rudko; Brendan Santyr; Joe Gati; Trevor Szekeres; Terry M Peters; Ali R Khan Journal: Hum Brain Mapp Date: 2013-12-13 Impact factor: 5.038
Authors: Andrey Finegersh; Christina Avedissian; Sadat Shamim; Irene Dustin; Paul M Thompson; William H Theodore Journal: Epilepsia Date: 2011-01-26 Impact factor: 5.864
Authors: Georges Naasan; Gil D Rabinovici; Pia Ghosh; Jonathan D Elofson; Bruce L Miller; Giovanni Coppola; Anna Karydas; Jamie Fong; David Perry; Suzee E Lee; Jennifer S Yokoyama; William W Seeley; Joel H Kramer; Michael W Weiner; Norbert Schuff; William J Jagust; Lea T Grinberg; Mochtar Pribadi; Zhongan Yang; Renee Sears; Eric Klein; Kevin Wojta; Howard J Rosen Journal: Neurocase Date: 2015-06-04 Impact factor: 0.881
Authors: Shahin Tavakol; Jessica Royer; Alexander J Lowe; Leonardo Bonilha; Joseph I Tracy; Graeme D Jackson; John S Duncan; Andrea Bernasconi; Neda Bernasconi; Boris C Bernhardt Journal: Epilepsia Date: 2019-03-19 Impact factor: 5.864
Authors: Norbert Schuff; Yu Zhang; Wang Zhan; Maryann Lenoci; Christopher Ching; Lauren Boreta; Susanne G Mueller; Zhen Wang; Charles R Marmar; Michael W Weiner; Thomas C Neylan Journal: Neuroimage Date: 2010-05-17 Impact factor: 6.556
Authors: Linda Marrakchi-Kacem; Alexandre Vignaud; Julien Sein; Johanne Germain; Thomas R Henry; Cyril Poupon; Lucie Hertz-Pannier; Stéphane Lehéricy; Olivier Colliot; Pierre-François Van de Moortele; Marie Chupin Journal: MAGMA Date: 2016-05-02 Impact factor: 2.310